Paxman AB (publ) (STO:PAX)

Sweden flag Sweden · Delayed Price · Currency is SEK
80.60
-0.40 (-0.49%)
Jul 11, 2025, 2:57 PM CET
49.81%
Market Cap 1.73B
Revenue (ttm) 272.09M
Net Income (ttm) 21.58M
Shares Out 21.37M
EPS (ttm) 1.12
PE Ratio 72.13
Forward PE 43.67
Dividend n/a
Ex-Dividend Date n/a
Volume 12,627
Average Volume 29,513
Open 81.00
Previous Close 81.00
Day's Range 79.20 - 81.00
52-Week Range 48.80 - 85.80
Beta 0.36
RSI 56.30
Earnings Date Aug 20, 2025

About Paxman AB

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to utilize state-of-the-art technological advances to develop a wearable medical cooling device, and the National University Hospital of Singapore for the development of a cooling and compression system. Paxman AB (publ) was founded in 1... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1996
Employees 105
Stock Exchange Nasdaq Stockholm
Ticker Symbol PAX
Full Company Profile

Financial Performance

In 2024, Paxman AB's revenue was 263.20 million, an increase of 19.30% compared to the previous year's 220.61 million. Earnings were 40.20 million, an increase of 382.55%.

Financial Statements

News

There is no news available yet.